Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Hybrid MRI-Radiation Therapy System May Improve Cancer Treatment

By HospiMedica staff writers
Posted on 07 Aug 2007
By combining the high-quality three-dimensional (3D) images of magnetic resonance imaging (MRI) with the intense tumor-killing X-rays of a linear accelerator, scientists are constructing a prototype that could for the first time enable powerful X-ray beams to become an effective treatment option for liver, stomach, and pancreatic cancers, which currently must be treated with surgery, drugs, or internal radioactive seeds, in most instances. More...
The hybrid device could also improve results for all cancer patients receiving radiation therapy.

Using a process called advanced real-time adaptive radiotherapy (ART), the prototype system will allow for near-real-time 3D magnetic resonance imaging (MRI) at the same time radiation is being administered. MRI can provide higher-quality images of tumors and organs than X-rays or computed tomography (CT) machines. Moreover, it is the only imaging technique that can provide high-quality, near-real-time 3D images inside the body.

Combining a linear accelerator used for radiation treatments and an MRI system is complex because they function on incompatible scientific and engineering principles. ART overcomes the issue by rotating an MRI machine and a linear accelerator together. The two machines are fixed with respect to each other and rotate in unison around the patient, obtaining images and delivering radiation treatment from all angles. This fixed-system concept decreases electromagnetic interference between the linear accelerator and MRI.

A finished prototype is expected by December 2007. According to the researchers, from the Alberta Cancer Board (Canada), the machine will improve the effectiveness of treatments for solid tumors, thereby reducing side effects. Furthermore, it could improve treatment for lung and prostate cancers, where it is still difficult to administer enough radiation doses to obtain a better chance of a cure.

The study's findings were presented at the 49th annual meeting of the American Association of Physicists in Medicine (AAPM) on July 22-26, 2007 in Minneapolis, MN, USA.


Related Links:
Alberta Cancer Board

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Radiofrequency Generator
GX1
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.